Dr. Kelley Discusses Biomarkers for Immunotherapy in HCC – OncLive
Dr. Kelley Discusses Biomarkers for Immunotherapy in HCCOncLiveR. Kate Kelley, MD, associate professor, University of California, San Francisco, discusses biomarkers for immunotherapy in hepatocellular carcinoma (HCC). In the advent of immunotherapy in… Continue reading
